Dr. Cedric W. Spak, MD

Dr. Spak practices at Texas Centers for Infectious Disease Associates PA in Fort Worth, Texas.

Dr. Spak's NPI, 1063575199, was assigned on December 19, 2006. Dr. Spak graduated from UT Southwestern Medical Center in 1999. Dr. Spak holds Texas license L1206.

Dr. Spak's primary practice is Texas Centers for Infectious Disease Associates PA, at 1025 College Ave, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 810-9811.

Dr. Spak's primary practice is Texas Centers for Infectious Disease Associates PA in Fort Worth, Texas. Dr. Spak is also affiliated with Baylor University Medical Center. The medical group on file is Texas Centers for Infectious Disease Associates. Dmand AI also links Dr. Spak to 4 more hospitals, 2 group practices and clinics, 2 home health agencies and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spak practices, 9 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Spak's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Spak is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Spak's licenses on file in 3 states: Texas, Minnesota and Washington.

Dmand AI lists acute sinusitis, acute skin infection, endocarditis, facial skin infection, hiv/aids, immune deficiency disease, joint or bone infection and pneumonia among the conditions Dr. Spak treats.

CMS data shows 17,808 Medicare services from Dr. Spak across 18 procedure codes in 2024, for 485 Medicare patients. Medicare paid $305,194 for them.

CMS counts 485 Medicare patients who saw Dr. Spak in 2024. The largest group is 65 to 74, with 245 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 3.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Spak's median patient age at 62, with 42% women.

In 2024, Dr. Spak wrote 1,962 Medicare Part D claims for 332 patients. 84% of them were for generic drugs. CMS names the drug for 1,818 of them, across 32 drugs with 11 or more claims each, at $814,841 in total drug cost. In 2023, CMS named 1,425 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Spak for performance year 2024, reported as part of a group. Dr. Spak accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 31 papers to Dr. Spak, published from 2008 to 2024. 2021 was the busiest year, with 7. The most frequent topics are COVID-19, SARS-CoV-2 and Kidney Transplantation. Dr. Spak has published most often in Proc (Bayl Univ Med Cent). Dr. Spak's most frequent co-authors are Robert Lawrence Gottlieb, MD, PhD, George J. Alangaden, MD and David Barrett Banach, MD.

CMS Open Payments shows 1,119 general payments to Dr. Spak from 43 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $163,002.

Dmand AI lists 4 awards for Dr. Spak, most recently Physician of the month in 2017. Dr. Spak serves on Credentialing at Baylor All Saints Medical Center Fort Worth and Sepsis Committee Baylor All Saints Medical Center Fort Worth.

Dr. Spak graduated from UT Southwestern Medical Center in 1999. Dr. Spak is a member of ACP, AMA, IDSA and TMA.

Dr. Spak is in network with 22 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.